Koninklijke Philips (PHG) Earnings Date & Reports

Key Takeaways

• Koninklijke Philips N.V. (PHG) is scheduled to report its third-quarter 2026 results in early November, following a second quarter in which comparable sales rose 4%.
• Investors will watch closely whether comparable order intake rebounds after a 1% dip in Q2 2026, which management attributed to large North American orders shifting into the third quarter.
• Full-year 2026 comparable sales growth guidance stands at 3% to 4.5%, while adjusted EBITA margin guidance was raised to 13.5% to 14.0%, partly reflecting a one-time U.S. tariff refund benefit.
• Underlying profitability remains under pressure from tariffs and cost inflation, with China demand a key source of uncertainty.
• Key metrics to monitor include comparable sales, order intake, adjusted earnings per share (EPS), and free cash flow.

Earnings Context and Why It Matters

Philips is a Dutch health technology company operating across Diagnosis & Treatment, Connected Care, and Personal Health segments. Its third-quarter 2026 report matters because it will reveal whether the company can sustain growth without the one-time U.S. tariff refund that boosted margins in the prior quarter. The print will also test whether the order book momentum management flagged — including large North American orders shifted into Q3 — materializes into stronger demand. For investors, the report offers a key checkpoint on the company's profitability recovery, margin trajectory, and ability to navigate tariff headwinds and a cautious China market.

Earnings Expectations

In the year-ago period (third quarter 2025), Philips reported sales of €4.30 billion, comparable sales growth of 3.3%, comparable order intake growth of 8%, and adjusted EPS of €0.36. Those figures serve as the baseline for this quarter's comparison.

For full-year 2026, the company has guided to comparable sales growth of 3% to 4.5%. On profitability, Philips raised its adjusted EBITA (earnings before interest, taxes, and amortization of acquired intangible assets) margin outlook to 13.5% to 14.0%, including an approximate one-percentage-point benefit from a U.S. tariff refund. Free cash flow guidance was also lifted to €1.5 billion to €1.7 billion.

Analysts and investors will be watching whether Q3 comparable sales stay within the guided range, whether order intake recovers after the Q2 decline, and whether the underlying adjusted EBITA margin — which was about 12.2% in Q2 excluding the tariff refund — continues to expand. In Q2 2026, Philips reported adjusted EPS of €0.49, up from €0.36 a year earlier, helped by a €186 million tariff refund.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to streamline your own research.

Market Reaction and Investor Sentiment

Sentiment heading into this report is mixed. After the Q2 2026 release, Philips shares declined even as adjusted EPS topped expectations, as investors focused on the 1% decline in order intake and the one-time nature of the tariff refund benefit that padded margins. The underlying adjusted EBITA margin of roughly 12.2% highlighted the ongoing pressure from tariffs and cost inflation.

Heading into Q3, investors will be looking for evidence that the large North American orders deferred from the second quarter have converted, that Europe's double-digit order growth persists, and that margins are stabilizing on an underlying basis. A softer-than-expected order intake figure or any sign of further China weakness could weigh on the stock, while a rebound in orders and resilient margins would likely be viewed favorably.

Forward Outlook and Key Factors to Monitor

Beyond the headline numbers, investors should track several forward-looking signals. Order intake will be the most important, given management's comment that certain large Connected Care orders in North America shifted into the third quarter. A strong rebound would support revenue visibility into 2027.

Tariff developments remain a central variable. Philips has said the 2026 outlook includes currently known tariffs, and any new or expanded trade measures could pressure gross margins further. The company is also navigating a cautious China market, where demand and processing times remain uncertain.

Margin execution will be another focal point. Philips has guided for an underlying full-year adjusted EBITA margin of 12.5% to 13%, and management expects a margin step-up in the fourth quarter. Progress on the company's three-year productivity program will be key to offsetting cost inflation.

Finally, watch free cash flow and any updates to full-year guidance. The raised free cash flow target of €1.5 billion to €1.7 billion includes the tariff refund benefit, so investors will assess whether cash generation remains on track on an underlying basis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations